146 related articles for article (PubMed ID: 7924634)
41. Further evaluation of an immunoprecipitation assay for TSH-receptor autoantibodies in Graves' disease.
De Bruin TW; Braverman LE; Brown RS
Metabolism; 1986 Dec; 35(12):1101-5. PubMed ID: 2878349
[TBL] [Abstract][Full Text] [Related]
42. A non-isotopic screening test for antibodies to TSH receptor: dot immunobinding assay.
Bakó G; Islam MN; Vértes M; Lenkey A; Farid NR; Leövey A
Acta Med Hung; 1989; 46(2-3):121-31. PubMed ID: 2812956
[TBL] [Abstract][Full Text] [Related]
43. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
[TBL] [Abstract][Full Text] [Related]
44. [Behavior of TBII (TSH receptor binding immunoglobulins) in multinodular struma].
Sussi PL; Burro A; Dagradi V; Abrescia F; Patuzzo E; Degara A
Chir Ital; 1987 Dec; 39(6):527-32. PubMed ID: 2895687
[TBL] [Abstract][Full Text] [Related]
45. Growth stimulating antibody, as another predisposing factor of Graves' disease (GD): analysis using monoclonal TSH receptor antibodies derived from patients with GD.
Ihara Y; Kanda Y; Seo M; Watanabe Y; Akamizu T; Tanaka Y
Endocr J; 2012; 59(7):571-7. PubMed ID: 22510947
[TBL] [Abstract][Full Text] [Related]
46. Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy.
Varewijck AJ; Boelen A; Lamberts SW; Fliers E; Hofland LJ; Wiersinga WM; Janssen JA
J Clin Endocrinol Metab; 2013 Feb; 98(2):769-76. PubMed ID: 23295466
[TBL] [Abstract][Full Text] [Related]
47. Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease.
Kahaly GJ; Diana T; Kanitz M; Frommer L; Olivo PD
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1006-14. PubMed ID: 31865369
[TBL] [Abstract][Full Text] [Related]
48. Iodide, cytokines and TSH-receptor expression in Graves' disease.
Schuppert F; Hiller W; Weinland G; Hoang-Vu C; von zur Mühlen A; Kohn LD
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():68-74. PubMed ID: 8981006
[TBL] [Abstract][Full Text] [Related]
49. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis.
Hidaka Y; Masai T; Sumizaki H; Takeoka K; Tada H; Amino N
Thyroid; 1996 Aug; 6(4):349-51. PubMed ID: 8875759
[TBL] [Abstract][Full Text] [Related]
50. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
Kahaly GJ; Diana T; Olivo PD
Endocr Pract; 2020 Jan; 26(1):97-106. PubMed ID: 32022598
[No Abstract] [Full Text] [Related]
51. [Anti-TSH receptor antibody (TBII, TSAb)].
Amino N; Kubota S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():277-9. PubMed ID: 16149508
[No Abstract] [Full Text] [Related]
52. Diagnostic sensitivity of two radio receptor assays (TRAK Assay and TRAK Dyno Human) for detection of TSH receptor antibodies.
Paunkovic N; Paunkovic J
Nucl Med Rev Cent East Eur; 2003; 6(2):119-22. PubMed ID: 14737725
[TBL] [Abstract][Full Text] [Related]
53. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy.
Leövey A; Kálmán K; Szabó T; Lente K; Sándor P; Balázs C
Acta Med Acad Sci Hung; 1980; 37(4):345-50. PubMed ID: 6263033
[TBL] [Abstract][Full Text] [Related]
54. Hypothyroidism preceding hyperthyroid Graves' disease in two children.
Mäenpää J
Acta Endocrinol Suppl (Copenh); 1983; 251():27-32. PubMed ID: 6132508
[TBL] [Abstract][Full Text] [Related]
55. [Antibodies against the TSH receptor (TSAb) in Graves' disease and other thyroid diseases].
Gómez Sáez JM; Navarro Moreno MA; Soler Ramón J; Bonnin Lafuente R
Med Clin (Barc); 1982 Dec 1-31; 79(10):437-40. PubMed ID: 6130193
[No Abstract] [Full Text] [Related]
56. [Progress in the pathogenesis of Graves' disease: approaches from animal models].
Nagayama Y
Nihon Rinsho; 2006 Dec; 64(12):2215-8. PubMed ID: 17154081
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.
Seo S; Sánchez Robledo M
J Endocrinol Invest; 2018 Dec; 41(12):1457-1468. PubMed ID: 30194634
[TBL] [Abstract][Full Text] [Related]
58. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring.
Matsuura N; Konishi J; Fujieda K; Kasagi K; Iida Y; Hagisawa M; Fujimoto S; Fukushi M; Takasugi N
Lancet; 1988 Jan 2-9; 1(8575-6):14-7. PubMed ID: 2891888
[TBL] [Abstract][Full Text] [Related]
59. The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.
Amashukeli M; Korinteli M; Zerekidze T; Jikurauli N; Shanava S; Tsagareli M; Giorgadze E
J Investig Med; 2013 Jun; 61(5):842-7. PubMed ID: 23612147
[TBL] [Abstract][Full Text] [Related]
60. Development of a luminescent bioassay for thyroid stimulating antibodies.
Evans C; Morgenthaler NG; Lee S; Llewellyn DH; Clifton-Bligh R; John R; Lazarus JH; Chatterjee VK; Ludgate M
J Clin Endocrinol Metab; 1999 Jan; 84(1):374-7. PubMed ID: 9920111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
